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Background: Surveillance of Surgical Site Infections (SSI) in 2010 found 39 % compliance with hospital guidelines
in Piedmont (Italy). The aim of the study was to estimate the appropriate use of antimicrobial prophylaxis and
compliance with hospitals guidelines in surgical wards.
Methods: This survey study took place in 21 surgery wards of 4 public hospitals. Forms were completed by public
health resident doctors together with a medical ward referent and infection control nurses. 15 consecutive surgical
procedures were randomly chosen from each ward. A total of 320 cases were analyzed. The study period was from
July 2012 to January 2013. Data were collected using a survey form. A final score variable from 0 to 4 was given to
each case. The results were compared with hospital and international guidelines. Data were analyzed using Epi-Info
software.
Results: Of the 320 cases collected, 63 were excluded; of the remaining 257 cases, 56.4 % of the procedures were
appropriate (score 4), 15.2 % were acceptable and 28.4 % were not acceptable. The study found an unjustified
continuation of antimicrobial prophylaxis in 17.1 % of the 257 cases, an unjustified re-start of antimicrobial therapy
in 9.7 % and a re-dosing omission in 7.8 %.
Conclusions: The study demonstrated critical problems in antimicrobial prophylaxis management in surgical wards
due to a lack of compliance between hospitals and national guidelines, a shortage of specific and updated
recommendations for some surgical interventions and incorrect local specific procedures. Coordination between
local and national recommendations, strengthening of evidence based decisions and continuous sharing of policy
updates are needed.
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The definition of “Surgical Site Infection” (SSI) was intro-
duced in the medical vocabulary in 1992 as a replacement
for the previous definition of “surgical wound infection”.
NNIS (National Nosocomial Infection Study) – NHSN
(National Healthcare Safety Network) recognize incisional
and organ/space SSIs using standardized surveillance cri-
teria [1].
Although they are potentially preventable, surgical site
infections continue to occur frequently, demonstrating
that the complete elimination of microbial risk is not* Correspondence: m.testa@unito.it
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unless otherwise stated.possible. Although infection control strategies have been
implemented, SSIs are a frequent cause of morbidity and
mortality. Patients with SSIs more frequently require
additional surgeries, re-hospitalization or ICU recovery,
with an increased mortality risk.
European Countries use a surveillance system consist-
ing of standardized protocols; methods of surveillance
were fully integrated into The European Surveillance
System (TESSy) in October 2010; the first report shows
the results of SSIs surveillance in Europe from 2008 to
2009, as well as the results of analysis of trends from
2006 to 2009 [2].
Every year, a national report is produced on SSIs data
from eleven Italian regions and one hundred hospitals;his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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interventions and 1.2 % for orthopedic interventions [3].
Piedmont (4,457,335 inhabitants; 337,160 surgical inter-
ventions with 99,535 Day Hospital) began surgical inter-
vention surveillance in 2005 [4, 5]. Since 2008, Piedmont
has participated in national and European surveillance with
an annual report. The most recent analysis demonstrates
comparable frequencies between Italian and European data
on 9,500 interventions from 2008 to 2011.
Antimicrobial prophylaxis is a high efficacy control
measure for SSIs that is defined as drug administration
before surgical-field bacterial contamination [6–8].
Recommendations for appropriate surgical antimicrobial
prophylaxis can be found in national and international
guidelines [7, 9–13]. In Italy, each hospital produces its
own protocol (hospital guidelines) that includes indica-
tions for the use of antimicrobial prophylaxis and therapy,
in agreement with a hospital Infection Control Committee
(ICC) composed of clinicians, pharmacists and microbiol-
ogists [14].
Beginning in 2008, Piedmont implemented an indicator
system to evaluate the organization, surveillance, control
and education activities relating to healthcare-associated
infections; in 2010, an indicator of SSI control was intro-
duced, including antimicrobial prophylaxis surveillance,
which showed conformance in only 39 % of cases.
As demonstrated by recent publications, the SSIs issue
has national and international relevance [15–18]. In 2006,
the Surgical Care Improvement Project (SCIP) was estab-
lished in the United States with the goal of reducing surgi-
cal complications by 25 % by 2010; three of the six SCIP
performance indicators related to SSI prevention con-
cerned antimicrobial prophylaxis administration: timing,
antibiotic selection and duration [19, 20]. These three as-
pects seem to be critical components of successful anti-
microbial prophylaxis in all available studies.
This study was conducted on a sample of interven-
tions for estimating, by means of a flowchart, the appro-
priateness of the use of antibiotic prophylaxis and the
compliance with hospital guidelines.Methods
The survey was conducted between July 2012 and
January 2013 within the regional programme for HAI
prevention and control, using data regarding patients
who, at that time, were currently admitted in the wards
included in the study. This observational descriptive study
was intended for the surveillance of antibiotic prophylaxis
use in surgical wards, as required from public hospitals by
the Piedmont county government. Data were collected by
the hospitals according to the regional plan of surveillance
and control of healthcare associated infection set by the
Regional public health directorate that yearly renewoperative indications (Regione Piemonte. Direzione Sanitá.
Settore prevenzione veterinaria: contact sanita.pubbli-
ca@regione.piemonte.it). The outcomes of the analysis,
developed by the Regional committee on healthcare
associated infection, were shared with the Regional public
health directorate and with each hospital of the network
trough reports and scientific publications.
Data were anonymously collected in collaboration with
Hospitals referent after obtaining a study approval from
each hospital Management Team.
Each patient admitted in one of the hospitals included
in the study, signed the consent of personal data pro-
cessing document. Hospital Management Teams in-
volved are responsible for data processing and managing
and agreed to the collection of data from medical re-
cords, carried out under the supervision of Hospital op-
erators. The analysis was performed using data collected
for institutional purposes and linked with a regional pro-
gram of surveillance (Circular No.1950/2001 ‘Requisiti
di minima per la prevenzione del rischio infettivo nelle
strutture ospedaliere della Regione Piemonte’, available
on line in the web site of the Italian National Centre for
Disease Prevention and Control-CCM: http://www.ccm-
network.it/documenti_Ccm/prg_area1/Inf_Oss/Normativa_
reg/Piemonte_Prev_minima_strutt_osped_01.pdf) therefore
ethics committee approval was not required.
A total of 21 surgical wards from four different hospitals
(re-named A, B, C, and D) were analyzed for a period of
6 months (from July 2012 to January 2013); of the 21
wards, there were five urologic surgery, four general sur-
gery, three vascular surgery, three orthopedic surgery, two
plastic surgery, one heart surgery, one thoracic surgery,
one neurosurgery, and one otolaryngology ward. For each
ward, data from almost 15 consecutive interventions ran-
domly chosen were collected, for a total of 320 cases.
A flowchart-form was used to collect data to simplify,
standardize and objectify the data collection process.
Forms were filled in by a team composed of public health
resident doctors together with a medical ward referent
and an infection control nurse (ICN). A final score vari-
able from 0 to 4 was given to each case. Hospital guide-
lines, generally based on 2008 national guidelines and
approved by ICC, were used as the standard reference.
The flow chart-form is divided into four sections.
The first section (Fig. 1) contains personal data (age, sex,
number of medical records) and intervention data (date,
contamination classification, International Classification
of Diseases ICD9 code, prosthesis, duration and
antibiotic use). In this section, interventions could be
excluded due to infection or antibiotic therapy.
The second section (Fig. 2) is a flow chart including
information about the appropriateness of the
antimicrobial prophylaxis.
Fig. 1 Flow chart. First part
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the antimicrobial prophylaxis: molecule, timing of first
administration, re-dosing, last administration, modality
and motivation for post-intervention antibiotic re-take.
Each of these criteria contributed to produce a final
score from 0 to 4.
The last section (Fig. 4) is a summary of the collected
data. This part allows the researcher to give a final
score to the appropriateness of the antimicrobialprophylaxis. Final scores are divided into three
categories: 0–2: not conforming with antimicrobial
prophylaxis; three: acceptable antimicrobial
prophylaxis; four: completely correct antimicrobial
prophylaxis.
Data were analyzed using the Epi-Info statistical software.
Results and discussion
During the study, 320 clinical records were analyzed. Of
these, 25 records were auto-compiled by ward personal
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Fig. 2 Flow chart. Second part
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with infection or antimicrobial therapy before the inter-
vention and those classified as class IV were excluded,
with 257 cases remaining. Characteristics of patients and
surgical procedures are reported in Table 1.
Hospital A procured 108 cases, hospital B 61 cases,
hospital C 75 cases, and hospital D 51 cases. The studyanalyzed different types of interventions by different
surgical disciplines. Urological and general surgery inter-
ventions constituted approximately 45 % of the sample;
orthopedic and vascular surgery interventions each
constituted 15 % of cases; and 20 % of interventions were
divided among otolaryngology, neurosurgery, heart sur-
gery and plastic surgery (Table 2).
Fig. 3 Antibiotic prophylaxis additional information
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Fig. 4 Antibiotic prophylaxis summary information
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Table 1 Patient and surgical procedure characteristic
Number Percent
Gender
- Missing a 1 0.4
- Male 155 60.3
- Female 101 39.3
Age, years
- Mean age 63.0 (44.1-81.9) -
- Age range 9-98 -
ASA Score
- Missing 69 26.8
- 1: in good general condition 29 11.3
- 2: patients with mild systemic disease 77 30.0
- 3: patients with moderate systemic
disease and functional limitations
70 27.2
- 4: patients with serious systemic disease 12 4.7
- 5: patients with very serious condition
with <24 h life expectancy, with or
without surgical intervention
0 0.0
Surgical wound classification
- Missing 3 1.2
- I (clean) 180 70.0
- II (clean/contaminated) 62 24.1
- III (contaminated) 12 4.7
- IV (dirty/infected) Excluded -
Implant of prosthesis
- Missing 3 1.2
- Yes 109 42.4
- No 145 56.4
Antibiotic prophylaxis needed
- Yes 217 84.4
- No 40 15.6
aWe consider as missing all values not recorded on the medical chart
Table 2 Interventions by hospitals
Surgical ward Hospital A Hospital B
Urologic (surgery) 32 15
General (surgery) 15 16
Orthopedic (surgery) - 15
Vascular (surgery) 31 -
Plastic (surgery) 15 -
Otolaryngologic (surgery) - 15
Neuro (surgery) - -
Heart (surgery) 15 -
Totala 108 61
aDue to mathematical approximation the algebraic sum of % values is 100.1. In Tab
Testa et al. BMC Surgery  (2015) 15:63 Page 7 of 11The final score analysis showed that 56.4 % of proce-
dures were completely correct, 15.2 % were acceptable
and 28.4 % were non-conforming. However, the percent
of procedures that were correct varied between the four
hospitals, from 43.8 % as the minimum in hospital A to
the maximum of 77.6 % in hospital B.
The analysis was performed by ward type; there was
significant variation from a minimum of 32.6 % in vascu-
lar surgery to a maximum of 100.0 % in heart surgery
(Table 3). The stratification using the American Society
of Anesthesiologists score (ASA score) and the interven-
tion class did not allow for the observation of significant
differences in conformance. Errors included antimicro-
bial therapy continuation for longer than the time limits
suggested by hospital protocols (17.1 %), antimicrobial
therapy re-starting without valid justification (9.7 %), re-
dosing omission (7.8 %), molecule not indicated (7.4 %)
and antimicrobial prophylaxis use in interventions with-
out protocol indications (6.2 %) (Table 4).
Frequent errors were analyzed to understand problems
characterizing different surgical areas, with results strati-
fied by surgical specialty. More variability was observed
in general surgery, urologic and vascular surgery, where
mistakes are concentrated in certain areas: antimicrobial
prophylaxis continuation (22.5 %) or antimicrobial ther-
apy retake (25 %) after the intervention in urologic sur-
gery, intra-operatory dose omission in general surgery
(18.8 %), incongruous continuation (30.2 %) and wrong
molecule in vascular surgery (20.9 %) (Table 5). An ana-
lysis of 44 interventions with unjustified antimicrobial
prophylaxis continuation found that in 70.5 % of cases
the drug was administered for more than 24 h and in 50
% of cases for more than 48 h.
The most common errors were studied using as the
denominator only the interventions for which that type
of error was possible; therefore, in Table 6 the frequen-
cies are more elevated; for example, the error of re-
dosing occurred in 90.9 % of cases.Hospital C Hospital D Number Percent
15 14 76 25.76
15 15 61 20.68
15 17 47 15.94
15 - 46 15.60
- 5 20 6.78
- - 15 5.08
15 - 15 5.08
- - 15 5.08
75 51 295 100
le 2 the value Total % has been corrected to 100
Table 3 Final scores for appropriateness of antibiotic prophylaxis by surgical specialty
Surgical ward ≤2 (not conforming) 3 (acceptable) 4 (correct) Total
N % N % N % N
Urologic (surgery) 21 30.9 14 20.6 33 48.5 68
General (surgery) 13 27.1 12 25.0 23 47.9 48
Vascular (surgery) 22 51.2 7 16.3 14 32.6 43
Orthopedic (surgery) 2 4.7 4 9.3 37 86.0 43
Plastic (surgery) 6 40.0 1 6.7 8 53.3 15
Heart (surgery) 0 0.0 0 0.0 15 100 15
Otolaryngologic (surgery) 5 38.5 0 0.0 8 61.5 13
Neuro (surgery) 4 33.3 1 8.3 7 58.3 12
Total (all interventions) 73 28.4 39 15.2 145 56.4 257
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resents approximately 40–50 % of total hospital-
prescribed antibiotics [21]. Indiscriminate antibiotic use
increases the prevalence of antibiotic-resistant bacteria and
predisposes patients to infections, such as Clostridium
difficile colitis [22, 23]. Clinical and efficacy studies on anti-
microbial prophylaxis have identified antibiotic choice, tim-
ing, intra-operatory re-dosing and duration as the key
points to ensure SSI prevention.
Our analysis found that antimicrobial prophylaxis did
not conform to guidelines in 28.4 % of cases; in contrast,
antimicrobial prophylaxis was correct in 56.4 % of cases.
This value is comparable to data in the literature that show
an adherence to guidelines of 48 % to 70.7 % [17, 24].Table 4 Frequency of antimicrobial prophylaxis-linked “errors” a
Type of error Number of
errorsa
Percent
Antimicrobial prophylaxis continuation 44 17.1
Antibiotic therapy re-start 25 9.7
Intra-operatory dose omission 20 7.8
“Wrong” molecule 19 7.4
Antimicrobial prophylaxis administered (without
a reason) when not needed
16 6.2
Antimicrobial prophylaxis not administered
(without a reason) when needed
7 2.7
Antimicrobial prophylaxis not administered
(with insufficient reason) when needed
1 0.4
Un-necessary intra-operatory dose 0 0.0
Premature first dose administration 1 0.4
Late first dose administration 0 0.0
Totalb 133/257 51.8
“Wrong”: molecule is not included in hospital guidelines
aDue to the high heterogeneity of antibiotic prophylaxis guide line published
in recent years, and compatibly with the aim of the study, specific ward
antibiotic prophylaxis protocols were accepted only when proven to be
evidence based and if approved by ICC
bTotal interventions = 257; multiple errors are possible for each interventionNot-uniformity in clinical record compilation, depend-
ing on hospital and ward, interfered with data collection.
Consultation with the ward referent helped with clarifi-
cation, in particular about antimicrobial prophylaxis tim-
ing and continuation; the presence of the ward referent
was crucial for doubtful cases because of their direct pa-
tient knowledge. It is important to standardize decisions
about antimicrobial prophylaxis; these types of process
evaluations should not require an interpretation of pre-
scribing behavior.
Two of the major limitations of the flowchart were:
– The flowchart lacks the ability to evaluate the
appropriate use of antibiotics that are not included
in hospital guidelines, but that have a compatible
spectrum (i.e., amoxicillin plus clavulanic acid
instead of cefazolin).
– In some cases, it was difficult to distinguish between
antimicrobial prophylaxis continuation and an antibiotic
therapy re-start. Heart surgery was the only category
to obtain a final score of 100 % correct; because of an
elevated Methicillin-Resistant Staphylococcus Aureus
(MRSA) isolation frequency, the heart surgery unit had
an internal protocol (including vancomycin + cefazoline)
that was validated by ICC and compliant with hospital
and national guidelines.
The national guidelines lack indications about anti-
microbial prophylaxis in plastic surgery interventions; in
one plastic surgery ward, an internal protocol was intro-
duced that was not validated by ICC and not compliant
with recent indications from the literature [25, 26].
The comparison between hospital and national guide-
lines showed some differences that might have influ-
enced the final scores of some interventions:
1) Use of glycopeptide: National guidelines recommend
the use of glycopeptides only in the case of MRSA
Table 5 Five most frequent errors by surgical specialty
Errors Urologic
surgery
General
surgery
Vascular
surgery
Orthopedic
surgery
Plastic
surgery
Heart
surgery
ORL Neuro
surgery
Total
N 68 48 43 43 15 15 13 12 257
n % n % n % n % n % n % n % n % n %
Antimicrobial prophylaxis continuation 15 22.5 7 14.6 13 30.2 2 4.6 4 26.7 0 0.0 1 7.7 2 16.7 44 17.1
Antibiotic therapy re-start 17 25.0 2 4.2 1 2.3 1 2.3 4 26.7 0 0.0 0 0.0 0 0.0 25 9.7
Intra-operatory dose omission 4 5.9 9 18.8 4 9.3 0 0.0 3 20.0 0 0.0 0 0.0 0 0.0 20 7.8
“Wrong” molecule 4 5.9 2 4.2 9 20.9 0 0.0 1 6.7 0 0.0 2 15.4 1 8.3 19 7.4
Antimicrobial prophylaxis administered (without a reason)
when not needed
1 1.5 4 8.3 7 16.3 0 0.0 1 6.7 0 0.0 3 23.1 0 0.0 16 6.2
“Wrong”: molecule is not included in hospital guidelines
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guidelines allow the administration of vancomycin
for patients coming from long-term care or for
patients who had been admitted to a hospital ward
1 week before the intervention. This protocol, which
was established based on recommendations from
specialists, was based on evidence that patients with
those features are more likely to be colonized by
MRSA. In Hospital C, the isolation of MRSA in
surgical wards was found to be approximately 50 %.
2) Use of piperacillin + tazobactam: National
guidelines limit the use of this type of antibiotic to
therapy, whereas the internal protocol of Hospital
C recommends their use in some specific
urological and general surgery interventions
involving the intestine.
3) Prophylaxis duration: National guidelines recommend
a singular administration of antibiotic, other than
for interventions with a high risk of contamination.
In the guidelines of Hospital D, the extension of the
prophylaxis in the first 24 h is recommended for
several interventions (general surgery, urological
surgery, vascular surgery, neurosurgery), without
considering the risk of contamination. Breast surgery is
another example of this problem: national guidelines
recommend a singular administration of cefazolin inble 6 “Real” frequencies of the most frequent errors by surgical sp
rors Urologic
surgery
General
surgery
Vascular
surgery
O
su
n % n % n % n
timicrobial prophylaxis
ntinuation
15/37 40.5 7/19 36.8 13/21 61.9 2/
tibiotic therapy re-start 17/25 68.0 2/5 40.0 1/3 33.3 1/
tra-operatory dose omission 4/4 100 9/10 90.0 4/4 100 0/
rong” molecule 4/62 6.5 2/37 5.4 9/31 29.0 0/
timicrobial prophylaxis
ministered (without a reason)
hen not needed
1/5 20.0 4/11 36.4 7/10 70.0 0/
rong”: molecule not included in hospital guidelinesASA ≥3 patients, with the possibility of continuation
for 24 h. Based on these recommendations, Hospital D
guidelines suggest three administrations of cefazolin in
the first 24 h for breast interventions.
Such a feature is extensively discussed in the scientific
literature; however, a clear and shared recommendation
still needs to be developed.
Recent remarks note problems with the extension of
prophylaxis and more studies are necessary to prove a real
improvement from prolonging antimicrobial prophylaxis
for 24 h, in terms of surgical site infection risk and health-
care costs [13].
Conclusion
This study shows a variation in compliance with national
and hospital guidelines; moreover, the lack of specific
recommendations for some interventions increases the
use of practices that are based on surgeon experiences
and are not always evidence based.
The study provided an opportunity to implement a
standardized instrument to collect data, with the aim of
obtaining an objective evaluation. The flowchart enabled
comparisons across different settings and in different op-
erative conditions. Even if the flowchart may be im-
proved, it was found to be a good operative tool.ecialty
rthopedic
rgery
Plastic
surgery
Heart
surgery
ORL Neuro
surgery
Total
% n % n % n % n % n %
16 12.5 4/4 100 0/15 0 1/5 20.0 2/9 22.2 44/126 34.9
6 16.7 4/4 100 0/0 - 0/0 - 0/5 0 25/48 52.1
0 - 3/3 100 0 0 0/0 - 0/1 0 20/22 90.9
42 - 1/20 5.0 0/12 - 2/6 33.0 1/10 10.0 19/213 8.9
1 0.0 1/5 20.0 0/0 - 3/7 42.9 0/1 0 16/40 40.0
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prophylaxis continuation, inappropriate antibiotic ther-
apy re-take, missed re-dosing, wrong molecules and un-
justified antimicrobial prophylaxis) indicate the need for
a scientific debate about controversial antimicrobial
prophylaxis features; training activities and audit tech-
niques are tools to address the question and obtain
shared and evidence-based recommendations.
The alignment of local policies with national recom-
mendations seems to be required; some differences be-
tween local protocols and national guidelines might be
caused by missing updates in guidelines.
Medical choices should be evidence-based, aiming
both to improve health-care quality and to reduce
health-related costs.
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